Ossiam’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-70
Closed -$23K 621
2024
Q4
$23K Sell
70
-472
-87% -$160K ﹤0.01% 598
2024
Q3
$181K Sell
542
-242
-31% -$76.9K ﹤0.01% 546
2024
Q2
$214K Buy
784
+40
+5% +$11.6K ﹤0.01% 529
2024
Q1
$257K Buy
744
+264
+55% +$86.8K ﹤0.01% 556
2023
Q4
$155K Buy
480
+4
+0.8% +$1.25K ﹤0.01% 604
2023
Q3
$171K Sell
476
-131
-22% -$50.5K ﹤0.01% 611
2023
Q2
$230K Buy
607
+307
+102% +$125K ﹤0.01% 586
2023
Q1
$144K Buy
300
+16
+6% +$7.49K ﹤0.01% 533
2022
Q4
$119K Hold
284
﹤0.01% 545
2022
Q3
$118K Buy
284
+256
+914% +$128K ﹤0.01% 533
2022
Q2
$14K Sell
28
-3,864
-99% -$2.01M ﹤0.01% 406
2022
Q1
$2.19M Buy
3,892
+3,823
+5,541% +$2.3M 0.06% 169
2021
Q4
$52K Buy
69
+48
+229% +$35.9K ﹤0.01% 389
2021
Q3
$16K Hold
21
﹤0.01% 421
2021
Q2
$16K Buy
+21
New +$12.8K ﹤0.01% 426
2021
Q1
Sell
-1,147
Closed -$669K 415
2020
Q4
$669K Sell
1,147
-420
-27% -$239K 0.02% 242
2020
Q3
$808K Sell
1,567
-1,268
-45% -$642K 0.03% 208
2020
Q2
$1.28M Buy
+2,835
New +$1.25M 0.08% 149

Other funds holding BIO